| abstract |
One embodiment relates to a selective agonist for the neuronal nicotinic acetylcholine receptor alpha 7 subtype for the prevention and treatment of diseases and conditions mediated by nicotinic acetylcholine receptors, which is pharmaceutically suitable Salt, prodrug or metabolite, and methods of use thereof. Another embodiment is a selective agonist, a pharmaceutically acceptable salt, prodrug or metabolite thereof, which is administered to a mammal in need thereof, a pharmaceutically effective amount of a neuronal nicotinic acetylcholine receptor alpha 7 subtype The method. |